Literature DB >> 19641371

Primary chondrosarcoma of the kidney: case report and review of the literature.

Stephan Buse1, Wolfgang Behnisch, Andreas Kulozik, Frank Autschbach, Markus Hohenfellner.   

Abstract

We present a case of primary renal chondrosarcoma, its diagnosis and management. Copyright 2009 S. Karger AG, Basel.

Entities:  

Mesh：

Year:  2009        PMID： 19641371     DOI： 10.1159/000224880

Source DB:  PubMed          Journal:  Urol Int        ISSN： 0042-1138            Impact factor:   2.089


  5 in total

1.  Primary mesenchymal chondrosarcoma with bilateral kidney invasion and calcification in renal pelvis: A case report and review of the literature.

Authors:  Duqun Chen; Z I Ye; Xionghui Wu; Bentao Shi; Lijun Zhou; Shuolei Sun; Benlin Wei; Shangqi Yang; Xiangming Mao; Yongqing Lai
Journal:  Oncol Lett       Date:  2015-05-22       Impact factor: 2.967

2.  Management of renal extraskeletal mesenchymal chondrosarcoma.

Authors:  Vitalie Gherman; Ciprian Tomuleasa; Catalina Bungardean; Nicolae Crisan; Victor-Dan Ona; Bogdan Feciche; Alexandru Irimie; Ioan Coman
Journal:  BMC Surg       Date:  2014-12-15       Impact factor: 2.102

3.  Primary Chondrosarcoma in L-shaped Crossed Fused Renal Ectopia Coexisting with Papillary Urothelial Carcinoma in Urinary Bladder - An Enigmatic Entity with Poor Prognosis.

Authors:  Mayank Kumar; Aasma Nalwa; Taruna Yadav; Poonam Elhence; Himanshu Pandey; Meenakshi Rao
Journal:  J Kidney Cancer VHL       Date:  2022-01-01

4.  Primary mesenchymal chondrosarcoma of the kidney with synchronous implant and infiltrating urothelial carcinoma of the ureter.

Authors:  Hua Xu; MuMin Shao; HuiLi Sun; ShunMin Li
Journal:  Diagn Pathol       Date:  2012-09-21       Impact factor: 2.644

5.  Primary mesenchymal chondrosarcoma of the kidney without HEY1-NCOA2 and IRF2BP2-CDX1 fusion: A case report and review.

Authors:  Atsushi Yamagishi; Osamu Ichiyanagi; Sei Naito; Hiromi Ito; Takanobu Kabasawa; Mitsunori Yamakawa; Norihiko Tsuchiya
Journal:  Oncol Lett       Date:  2019-11-22       Impact factor: 2.967
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.